-
Something wrong with this record ?
Aberrant tolerogenic functions and proinflammatory skew of dendritic cells in STAT1 gain-of-function patients may contribute to autoimmunity and fungal susceptibility
Z. Parackova, I. Zentsova, P. Vrabcova, A. Sediva, M. Bloomfield
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Gain of Function Mutation * MeSH
- Autoimmunity genetics MeSH
- Dendritic Cells metabolism MeSH
- Candidiasis, Chronic Mucocutaneous * genetics MeSH
- Humans MeSH
- Mutation MeSH
- STAT1 Transcription Factor MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
STAT1 gain-of-function (GOF) mutations underlie an inborn error of immunity hallmarked by chronic mucocutaneous candidiasis (CMC). Beyond the fungal susceptibility, attributed to Th17 failure, over half of the reported patients suffer from autoimmune manifestations, mechanism of which has not been explained yet. We hypothesized that the STAT1 mutations would affect dendritic cells' (DCs) properties and alter their inflammatory and tolerogenic functions. To test the hypothesis, we generated monocyte-derived DCs (moDCs) and tolerogenic DCs (tDCs). Functional and signaling studies, co-culture experiments and RNA sequencing demonstrated that STAT1 GOF DCs were profoundly altered in their phenotype and functions, characterized by loss of tolerogenic functions, proinflammatory skew and decreased capacity to induce Th17. Cytokine signaling, autophagy and metabolic processes were identified as the most prominently altered cellular processes. The results suggest that DCs are directly involved in STAT1 GOF-associated immune pathology, possibly contributing to both autoimmune manifestations and the failure of antifungal defense.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23004775
- 003
- CZ-PrNML
- 005
- 20230425171719.0
- 007
- ta
- 008
- 230418s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.clim.2022.109174 $2 doi
- 035 __
- $a (PubMed)36372319
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Parackova, Zuzana $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, Prague, Czech Republic. Electronic address: zuzana.parackova@fnmotol.cz
- 245 10
- $a Aberrant tolerogenic functions and proinflammatory skew of dendritic cells in STAT1 gain-of-function patients may contribute to autoimmunity and fungal susceptibility / $c Z. Parackova, I. Zentsova, P. Vrabcova, A. Sediva, M. Bloomfield
- 520 9_
- $a STAT1 gain-of-function (GOF) mutations underlie an inborn error of immunity hallmarked by chronic mucocutaneous candidiasis (CMC). Beyond the fungal susceptibility, attributed to Th17 failure, over half of the reported patients suffer from autoimmune manifestations, mechanism of which has not been explained yet. We hypothesized that the STAT1 mutations would affect dendritic cells' (DCs) properties and alter their inflammatory and tolerogenic functions. To test the hypothesis, we generated monocyte-derived DCs (moDCs) and tolerogenic DCs (tDCs). Functional and signaling studies, co-culture experiments and RNA sequencing demonstrated that STAT1 GOF DCs were profoundly altered in their phenotype and functions, characterized by loss of tolerogenic functions, proinflammatory skew and decreased capacity to induce Th17. Cytokine signaling, autophagy and metabolic processes were identified as the most prominently altered cellular processes. The results suggest that DCs are directly involved in STAT1 GOF-associated immune pathology, possibly contributing to both autoimmune manifestations and the failure of antifungal defense.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a aktivační mutace $7 D000073659
- 650 _2
- $a autoimunita $x genetika $7 D015551
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a transkripční faktor STAT1 $7 D050794
- 650 12
- $a kandidóza chronická mukokutánní $x genetika $7 D002178
- 650 _2
- $a dendritické buňky $x metabolismus $7 D003713
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zentsova, Irena $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, Prague, Czech Republic
- 700 1_
- $a Vrabcova, Petra $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, Prague, Czech Republic
- 700 1_
- $a Sediva, Anna $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, Prague, Czech Republic
- 700 1_
- $a Bloomfield, Marketa $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, Prague, Czech Republic
- 773 0_
- $w MED00005218 $t Clinical immunology (Orlando, Fla.) $x 1521-7035 $g Roč. 246, č. - (2023), s. 109174
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36372319 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425171716 $b ABA008
- 999 __
- $a ok $b bmc $g 1925080 $s 1190984
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 246 $c - $d 109174 $e 20221111 $i 1521-7035 $m Clinical immunology $n Clin Immunol $x MED00005218
- LZP __
- $a Pubmed-20230418